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Anti-DNA antibodies form immune deposits at distinct glomerular and
vascular sites. To investigate the capacity of lupus autoAb to produce
glomerular immune deposits (ID) and nephritis, 24 murine monoclonal
(m) anti-DNA antibodies (Ab), derived from either MRL-lpr/lpr, SNFI
or NZB lupus-prone mice and selected based on properties shared with
nephritogenie Ig, were administered i.p. (as hybridomas) and iv. (as
purified Ig) to normal mice; at least four mice/mAb were evaluated.
Three general patterns of immune deposit formation (IDF) were ob-
served: extracellular ID within glomeruli (± blood vessels, N = 8);
intranuclear ID (N = 5); or minimal or no ID (N = 11). The four MRL
m anti-DNA Ab that produced significant extracellular ID demonstrated
different disease profiles including: (a) mesangial and subendothelial ID
with anti-basement membrane staining, associated with proliferative
glomerulonephritis, PMN infiltration, and proteinuria; (b) diffuse fine
granular mesangial and extraglomerular vascular ID, associated with
proliferative glomerulonephritis and proteinuria; (c) dense intramem-
branous ID and intraluminal ID, associated with capillary wall thicken-
ing, mesangial interposition and expansion, aneurysmal dilatation and
intraluminal occlusion of glomerular capillary loops, and heavy protein-
uria; and (d) mesangial and extraglonierular vascular ID, associated
with mild segmental mesangial expansion, without proteinuria. These
MRL mAb were derived from four different mice, and they had variable
pls and isotypes. They all cross reacted with multiple autoantigens
(autoAg), however, their autoAg binding profiles were distinguishable.
Among the SNFI derived mAb, four produced histologically and
clinically indistinguishable disease characterized by diffuse mesangial
and capillary wall ID, associated with cellular proliferation/infiltration
and proteinuria. Three of the four mAb were derived from the same
mouse and were clonally related; they were: IgG2b with SWR allotype,
relatively cationic, highly cross reactive with similar Ag binding pat-
terns, idiotypically related and encoded by identical VH and nearly
identical VL sequences. We conclude that both the capacity of lupus
autoAb to form ID and the location of IDF are dependent on properties
unique to individual 1g. The results also indicate that the Ag binding
region of the autoAb is influential in this process, and they suggest that
multiple Ab-Ag interactions contribute to IDF in individuals with lupus
nephritis. Furthermore, these observations raise the possibility that the
pathologic and clinical abnormalities resulting from these interactions
are influenced by the location of IDF, and that the dominant interaction,
in a given individual, may be highly influential in the phenotypic
expression of nephritis.
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It is generally appreciated that anti-DNA antibodies (Ab) are
important contributors to glomerular immune deposit formation
in individuals with systemic lupus erythematosus [1—3]. How-
ever, the severity of nephritis is not necessarily related to the
level of circulating anti-DNA Ab. Many lupus patients with high
serum anti-DNA Ab titers do not have severe disease, and
conversely, patients with severe disease may have low or
barely detectable circulating Ab levels. Furthermore, there are
inbred strains of lupus mice with elevated serum levels of
anti-DNA Ab that do not develop glomerular disease [1, 4, 5].
Because of these observations, many investigators have con-
cluded that characteristics unique to individual pathogenic
anti-DNA Ab influence their capacity to form immune deposits
and produce nephritis. To address this issue directly, we and
others have examined Ig eluted from mice and patients with
active lupus nephritis [2, 4, 6—9]. It has been demonstrated that
nephritogenic Ab are predominantly IgG, and they fix comple-
ment. Although nephritogenic Ig are more cationic than their
serum counterparts in most murine lupus strains, anionic Ig are
also prominent, and in some strains the presence of cationic
autoantibodies is not sufficient for the development of nephritis
[3, 4, 6, 91. Nephritogenic Ig are enriched for anti-DNA and
other autoAb activity (compared to serum), and both compo-
nents (anti-DNA Ab and other Ig) cross react extensively with
a variety of non-nucleic acid autoAg [6, 71. Additionally, a large
fraction of nephritogenic Ig (within a given strain) share idio-
typic markers [6, 9, 101. Collectively, these latter observations
indicate that properties unique to the Ag binding regions of
pathogenic autoAb may be influential in the initiation of im-
mune deposit formation. In this regard, we and others observed
that a subgroup of anti-DNA Ab cross reacted with intrinsic
glomerular Ag, in vitro, such as cell surface proteins and
basement membrane constituents [11—181. Furthermore, some
anti-DNA Ab produced glomerular immune deposits after ad-
ministration to normal animals, by cross reacting directly with
intrinsic glomerular Ag in vivo [14, 19].
The present studies were undertaken to expand these obser-
vations. Our aim was to define a panel of monoclonal (m)
autoAb that could both produce immune deposits and transfer
disease to normal animals. We reasoned that by doing so, we
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Methods
Animals
(AKRXDBA/2)F1 and Balb/c mice were purchased from the
Jackson Laboratory (BarHarbor, ME, USA) (SWRxNZB)F1
and (NZBxSWR)F1 were bred in our laboratory as previously
described [20] and are designated SNFI mice.
Production and characterization of hybridoma AutoA 1'
B cell hybridomas and their mAb products were selected
from two large panels derived from MRL-lpr/lpr mice [21]; and
SNFI and NZB mice [9, 20, 22]. Sixteen MRL mAb were
selected on the basis of Ag binding and charge properties shared
with Ig eluted from the kidneys of MRL-lpr/lpr mice with active
lupus nephritis [6]. (The MRL nephritogenic Ab were predom-
inantly IgG, with cross reactive Ag binding properties and
varying charge; they also shared idiotypic properties.) The
MRL-lpr/lpr mAb all reacted with ssDNA, and many cross
reacted with a variety of self-Ag including: double stranded
DNA, rabbit thymus extract (containing the SniRNP complex),
an extract of extracellular glomerular proteins [14], cardiolipin,
hemoglobin, and/or lipopolysaccharide. Their charge varied
with p1's from 5.1 to 8.0.
Eight SNF1 and NZB mAb, previously characterized in
vitro, were selected for in vivo analysis [9, 20, 22]. Three SNFI
mAb, 550, 564 and 567, were lgG2b with the SWR allotype,
cationic (p1's = 8.28, 8.32, 8.15), had similar Ag binding
patterns, and shared idiotypic properties with each other and
with nephritogenic 1g. (Ig eluted from SNFI nephritic kidneys
are predominantly cationic IgO, enriched for autoAg binding
properties, and they share idiotypic markers, IdLNFI). These
three Ig were independently derived hybridomas from a single
SNFI mouse, and molecular analysis indicated that they arose
from a single B cell precursor [23, 24]. They had identical VH
region nucleotide sequences, however, their VK region se-
quences differed from each other by one to three nucleotide
substitutions. Another SNF1 mAb, 548, a cationic (p1 = 8.65),
1gW with the NZB allotype, also shared idiotypic properties
with nephritogenic Ig, but it was derived from a separate mouse
and used a VH gene (VH family 7183) distinct from 550, 564 and
567 (VR family J558). The mAb 317, an SNFI derived, cationic
(p1 = 7.87), IgG2a, with the NZB allotype, shared idiotypic
properties with nephritogenic 1g. Three other mAb did not
share the nephritogenic idiotype IdLNF1: 532 (an SNFI de-
rived, 1gG2b, p1 = 7.14, SWR allotype), 205 (an NZB derived
IgG2a, p1 = 6.39) and 524 (an SNFI derived, IgG2b, p1 = 7.14,
SWR allot ype).
mAb were purified from hybridoma supernatants by affinity
chromatography [14]. The Ag binding properties of the MRL mAb
were examined by both direct binding and competitive inhibition
in ELISAs using the following purified Ag: ssDNA, dsDNA,
SmRNP and glomerular extract [6, 14, 21]. Isotype determination
and isoelectric focusing of Ig were performed using previously
described methods [6, 14]. VH gene family usage was determined
by a modification of the Manser and Gefter technique [21, 25] or
by hybridization to Northern blots [26].
Administration of murine hybridomas and purified mAb to
normal mice
Murine hybridomas. Ten days after pristane-priming, 5 )< 10°
hybridoma cells were injected into the peritoneum of either
four- to six-week-old (AKRxDBA/2)Fl mice (if the hybridoma
was derived from an MRL-lpr/lpr mouse) or into four- to six-week-
old pre-autoimmune SNFI mice (if the hybridoma was derived
from either an NZB or SNF1 mouse). In parallel, either age-
matched, pristane-primed normal mice or PBS-injected, pristane-
primed, preautoimmune SNFI mice were used for comparison.
After 7 to 21 days, mice that developed visible ascites and/or
tumor growth were tail-bled, and their serum was tested for:
anti-DNA Ab activity (ELISA), antinuclear Ab activity (indirect
immunofluorescence; IF) [14] and cryoglobulinemia (incubation of
serum at 4°C for 72 h). Only those animals that developed both
visible ascites (and/or tumors) and serum anti-DNA Ab activity
were subjected to further examination. Although the time required
to develop ascites varied, mice were always sacrificed three to five
days after the onset of visible ascites. Observations were made on
at least four animals that developed ascites in each group. Urine
protein excretion was measured in the (AKRxDBA/2)Fl using the
Bio-Rad Assay (Bio-Rad, Richmond, California, USA) on 24 hour
collections obtained in metabolic cages [27]. After urine collection
the animals were sacrificed, and blood, ascites, kidneys and other
organs were isolated and saved for further study.
Kidney sections from each animal were analyzed by direct
IF, and electron microscopy (EM), as previously described
[271. For light microscopy (LM), one entire kidney from each
animal was fixed in 10% formalin and embedded in paraffin. The
number of nuclei/glomerulus and glomerular size were determined
as previously described [28]. Briefly, multiple 4 pm sections
through the center of the longitudinal axis of each whole kidney
were obtained, and they were stained with hematoxylin and eosin.
The cross sectional diameter and the number of nuclei/glomerulus
were determined on thirty consecutive glomeruli, using an ocular
micrometer. For comparative analysis, the ten largest glomeruli
on each slide were utilized. This maneuver increases the proba-
bility that measurements were determined on sections through the
middle of the glomerulus (as opposed to the poles) and is a more
accurate indicator of glomerular volume. Quantitative analyses
were performed on animals selected at random from each group.
Statistical evaluation of the groups was performed by one-way
analysis of variance using nonparametric statistics by Kruskal-
Wallis one-way analysis of variance by ranks [29, 30]. Where
appropriate, the groups were compared using the Mann-Whitney
U test [29, 30].
Isoelectric focusing of Ig deposited within glomeruli was per-
formed by direct elution of Ig from tissue sections and previously
described methods [6, 9]. Briefly, 25 pm sections were washed
thoroughly with PBS and then applied directly to the gel (1%
agarose). After 30 to 60 minutes of electrophoresis, the sections
were removed, and electrophoresis was continued for a total of
two hours. After transfer to nitrocellulose the Ig were visualized
using isotype-specific goat anti-mouse Ig by using either the
alkaline phosphatase method previously described or the ECL
detection system (Amersham Corporation, Arlington Heights,
illinois, USA). In pilot studies using 25 tim kidney sections
derived from normal mice, Ig was not detected by this method,
indicating that serum Ig did not influence the results.
could, in turn, more precisely identify the target ligands and
determine the relevant V gene sequences of pathogenic autoAb.
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Table 1. Su
depo
mmary of glomerular, tubular and vascular immune
sits induced by MRL-lpr/lpr m anti-DNA Ab
mAb
#
Immune deposits
Glomerular Vascular Tubular
mes
H238 mes
capillary wall
H221 intraluminal
mes/subendo
11161 mes
capillary wall
Abbreviations are: bm, basement
subendo, subendothelial.
Administration of purified 1g. In separate experiments, I to 2
mg of purified MRL-lpr/lpr mAb were injected i.v. to normal
four- to six-week-old BALB/c mice that had undergone unine-
phrectomy two weeks prior to injection. After four to six hours,
the animals were sacrificed, and the kidneys were evaluated by
direct IF and LM.
Results
Following administration of either hybridomas or their cor-
responding anti-DNA mAb to normal mice, three general IF
patterns were observed: (a) extracellular immune deposits
within glomeruli and blood vessels (# = 8); (b) intranuclear Ig
deposition within cells of the kidney and other organs (# = 5);
and (c) no detectable immune deposits (# = 11). Eight mAb (4
MRL, 4 SNF1) that reproducibly produced extracellular im-
mune deposits within glomeruli blood vessels were subjected
to further in vivo and in vitro analysis. At least four animals in
each group were evaluated (5 for SNFI), and in all cases
immune deposits were visualized in each animal within the
groups. The pattern of immune deposits and the disease profile
were indistinguishable between animals within a group with the
exception noted below (H 147). Many of the mAb (# = 11)
either did not form immune deposits or produced only minimal
mesangial deposits that were indistinguishable from those in
animals that received only pristane, despite the production of
high serum levels of circulating anti-DNA Ab; three are pre-
sented for comparative purposes. Every animal used in the
study had elevated serum levels of anti-DNA Ab, and in many
cases the anti-DNA Ab titers in the animals that did not form
significant immune deposits were higher than those that did (not
shown). The mAb that produced intranuclear deposits (with no
extracellular deposits) are the subject of a separate report (5
mAb: 3 from MRL, I SNF, I NZB) [28]. For purposes of
presentation, the MRL and SNF1 mAb will be considered
separately.
The results of the in vivo analyses of the MRL mAb are
presented in Figures 1 to 4 and Tables I and 2, The location of
immune deposits varied with the administered mAb. This was
associated with differences in the morphologic and clinical
expression of disease; multiple histologic and clinical patterns
were observed. Representative observations from each group
(mAb) are illustrated. With a few notable exceptions (see
below), following i.v. injection the MRL mAb produced im-
mune deposits in a pattern that was indistinguishable from the
mAb
Nuclei!
glomerulus
(N)
Glomerulai-
size pin
(N)
Proteinuria
mg/day
(N)
Hl47 44•3 1b
(3)
107 6.7
(3)
1.8 o.4
(4)
H238 48.7 38b
(3)
107 26b
(3)
1.9 0.6
(4)
H221 32.0 2.7
(4)
87 Q.7
(4)
3.8 l.2a
(7)
Hl61 32.5 3.5
(2)
83 1.5
(2)
1.0 0.2
(3)
Pooled resultsc 27.4 0.8
(13)
80.4 1.3
(13)
0.9 0.1
(8)
IF pattern in the mice that received the corresponding hybrid-
omas. However, since the goal of the i.v. studies was to
determine the capacity of the purified Ig to form glomerular
immune deposits, these animals were sacrificed after four to six
hours, and neither histologic nor clinical parameters of nephritis
were evaluated. For purposes of clarity, the results for each
mAb will be presented separately, however, they are also
summarized in Table 1. Representative results from mice that
received hybridomas and produced ascites with elevated serum
anti-DNA Ab levels but did not form immune deposits, are
indicated in Table 2 for comparison.
H147 produced granular mesangial and subendothelial depos-
its in all animals (Fig. I). In two of the five mice that received
the H147 hybridomas, linear staining along capillary loops,
glomerular capsules, tubules and vessels was also observed
(Fig. I). To further evaluate the linear staining pattern, an
additional group of five mice was studied: two developed
prominent diffuse linear deposits identical to those described
above; two had faint or no linear basement membrane staining,
and one animal died prior to evaluation. This linear pattern was
not found in any of the mice that received purified H147 Ig i.v.
Proliferative glomerulonephritis with PMN infiltration, and
proteinuria was present in all the Hl47 hybridoma mice (Table
2). Following elution and IEF of the Ig derived from the kidneys
of the mice that received the hybridomas, IgG bands were
observed in a pattern identical to that of purified 11147; 1gM
were not visualized.
After administration of hybridomas, H238 produced diffuse
fine granular mesangial, capillary wall, and extraglomerular
vascular deposits (Fig. 2). An identical pattern was also ob-
served after i.v. injection of H238, however the intensity of
staining was less in all locations. All of the hybridoma mice
developed mesangial proliferation and expansion, PMN infiltra-
tion, and proteinuria (Table 2). IEF of the Ig eluted from the
kidneys of the hybridoma mice indicated that the major 1gM
band was identical to purified H238; an additional minor 1gM
band was also visualized, but IgG bands were not observed.
Capillary wall and dense intraluminal IgG deposits were
H 147 linear bm
Table 2. Quantitative glomerular morphology and 24-hour urine
protein excretion in mice injected with MRL anti-DNA antibody
producing hybridomas
linear
small vessels
fine granular
none
small vessels
intimal
liner
none
none
none
membrane; mes, mesangial;
(N) = number of mice evaluated in each group
P < 0.05; b p < 0.01, compared to pooled results
C Pooled results from H73 (# = 4), H32 (# = 6) and H149 (# = 3)
mice; they produced ascites and elevated serum anti-DNA levels but
did not produce either intranuclear or extracellular immune deposits.
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Fig. 1. Histologic evaluation of kidneys from normal 4- to 6-week old mice following administration of H147. (a) Direct IF of kidney from mouse
that received H 147 hybridomas: linear deposits of IgG along glomerular capillary loops, glomenilar capsules, tubules and extraglomerular vessels;
granular IgG deposits were also observed within glomeruli (270 x). (b) Direct I.F. of kidney from mouse that received affinity purified H147, 4 hours
after intravenous injection: IgG within glomeruli, including capillary loops and mesangium; tubular and vascular deposits were not observed
(200 x). (c) L.M. of kidney from mouse that received H 147 hybridomas: enlarged glomerulus with cellular proliferation and PMN infiltration
(350 x). (d) EM of kidney from mice that received H 147 hybridomas: arrows indicate mesangial deposits; subendothelial deposits were observed
more abundantly in other fields. Arrow heads indicate foot process fusion (3500X). Fiber bundles with the ultrastructural appearance of collagen
were observed within the mesangium (not shown).
visualized within glomeruli of all mice that received H22l
hybridomas (Fig. 3). This was associated with capillary wall
thickening, mesangial interposition and expansion, aneurysmal
dilatation and intraluminal occlusion of glomerular capillary
loops, and heavy proteinuria (Table 2). The intraluminal depos-
its were reminiscent of immune deposits associated with cryo-
globulinemia [311, however, the mice did not have detectable
cryoglobulins in their serum. The intraluminal deposits were
not visualized following i.v. injection of purified H221. IEF of
Ig eluted from the kidneys of the hybridoma mice, demon-
strated a single band with a p1 of 5.1, and IgG2a was the only
isotype detected.
Following administration of either H 161 hybridomas or puri-
fied H16l, mesangial and extraglomerular vascular deposits
were observed (Fig. 4). The hybridoma mice developed seg-
mental mesangial expansion and mild mesangial cell prolifera-
tion. Glomerular and extraglomerular vascular occlusion were
also observed. The level of proteinuria was not significantly
different from the control mice. IEF of eluted Ig revealed IgG with
a p1 of approximately 7.0 (6.8 to 7.2) and the absence of 1gM.
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Fig. 2. Histologic evaluation of kidneys from
normal 4- to 6-week-old mice following
administration of H238 hybridomas. (a) Direct
I.E.: diffuse fine granular mesangial and
capillary wall 1gM deposits; in addition there
are fine granular deposits in extraglomerular
vessels (240x). (b) L.M.: enlarged
hypercellular glomerulus with PMN infiltration
and mesangial expansion (400x). (c) EM,:
PMNs (arrows) and lymphocyte (star)
infiltration with mesangial cell proliferation
(arrow heads) (2400x).
Although the mAb were selected because they cross reacted
with multiple autoAg, in a manner analogous to Ig eluted from
the kidneys of mice with active nephritis, each Ab had distinct
profile of Ag binding to the panel of autoAg (Table 3). In
addition to the greater reactivity to dsDNA and SmRNP, H22l
could be further distinguished from H147 by reactivity to
lipopolysaccharide and levan (Hl47 did not react with these Ag)
[21]. The Ag binding specificities of the mAb that formed
immune deposits, using this limited group of autoAg, could not
be differentiated from the mAb that did not form deposits (data
not shown), however, this does not exclude the possibility that
the two groups of mAb differ in their ligand binding specificities for
other unknown autoAg(s). The Ig subclass, charge, and VH gene
use varied among the MRL-derived mAb that formed immune
deposits, and it was not possible to distinguish them, by these in
vitro properties, from the mAb that did not form deposits.
Three general IF patterns were also observed for the SNF1
mAb. One group, consisting of 550, SM, 567, and 548, produced
extracellular glomerular immune deposits; another group pro-
duced only intranuclear deposits (317 and 205; [28]); and two
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Fig. 3. Histologic evaluation of kidneys from
normal 4- to 6-week-old mice following
administration of H221 hybridomas. (a) Direct
I.F.: Diffuse dense intraluminal and capillary
wall deposits of IgG (300x). (b) L.M.
Thickened appearance of glomerular capillary
walls, capillary loop dilatations with
homogeneous intraluminal material (450x). (c)
E.M.: large amorphous electron dense
deposits within distended capillary lumen
corresponding to IgG deposits by IF. above
(star); foot process fusion (arrowheads), and
thickened capillary walls associated with
electron dense deposits, and mesangial
interposition. Mesangial expansion is also
present (5000x).
j
cA
A j' 'ft
n
a
 
I' 
a
 
4 
-
l 
Si
 S 3 
4 
*
 iii 
A
 
t 'V
 -4
 
I 
p 
Fig. 4. Histologic evaluation of kidneys from normal 4- to 6-week-old mice following administration of H161 hybridomas. (a) Direct IF.: Dense
granular mesangial IgG deposits with fine granular deposits of IgG involving some capillary walls (350x); (b) Direct I.F.: a vessel outside the
glomerulus with granular IgG deposition limited to the intimal surface (350x); (c) L.M,: segmental mesangial expansion with borderline
hypercellularity (300x); (ci) L.M.: hyalin thickening of a vessel wall (450x); (e) E.M.: numerous electron dense deposits within the mesangium
(arrows) (3900x); (f) EM.: dense intraluminal deposits (arrows) corresponding to IF deposits in (a) (6900x).
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Fig. 5. Histologic evaluation of kidneys from 4- to 6-week-old SNFJ mice following administration of anti-DNA producing hybridoma. (a) I.F. and
(b) L.M. from 532 injected mice. This appearance was not significantly different from age-matched PBS-injected, pristane-primed SNFI mice. (c)
I.F. and (d) L.M. from 567 injected mice. (c) Diffuse mesangial and capillary wall deposits involved all glomeruli. (L.M. and IF. are 300x) (d)
Glomerular hypercellularity with PMN infiltration. The glomerular mAb 560, 564, and 548 were indistinguishable from 567.
mAb did not produce immune deposits (524 and 532). In
contrast to the MRL mice, the morphologic and clinical expres-
sion of disease among the individual mice that received SNFI
mAb, 550, 564, 567, and 548, were indistinguishable by IF, LM
and EM. A representative example is illustrated in Figure 5; the
disease was characterized by diffuse mesangial and capillary
wall deposits, mononuclear cellular proliferation/infiltration and
PMN infiltration. These abnormalities were observed in all
animals within each of the groups (5 mice/mAb).
Discussion
In these studies m anti-DNA Ab derived from lupus mice
produced glomerular and vascular immune deposits in normal
and pre-autoimmune mice following adoptive transfer. Each
immune-deposit forming Ab consistently produced the same
abnormalities in individual animals, however the location of
immune deposits varied among m Ab. In each case, the sole or
principal Ig within the lesions was the administered 1g. Immune
deposit formation, per Se, was not purely a quantitative phe-
nomenon, because many mice had elevated serum anti-DNA
Ab levels without immune deposits, and immune deposits were
observed after i.v. injection of relatively small quantities of Ab.
Furthermore, the observed differences in the location of im-
mune deposits with individual Ab were not due purely to
quantitative differences in circulating Ab levels for similar
reasons. It is likely, therefore, that the physical and immuno-
logic properties of Ig influenced both their capacity to form
immune deposits and the site of immune deposit formation
within glomeruli and blood vessels. These properties as well as
potential factors contributed by the experimental model war-
rant further discussion.
The capacity of a subgroup of anti-DNA Ab to form immune
deposits, whereas other isotype-matched autoAb did not, is
consistent with an influential role of the Ag binding region in
this process. This was not unexpected, because we had previ-
ously observed that immune deposit formation was not pro-
duced by all anti-DNA Ab on passive transfer [14]. The
influence of the Ag binding region was also suggested by our
previous analysis of Ig eluted from lupus kidneys: autoreactiv-
ity, cross-reactive autoAg binding specificities and shared idio-
types distinguished nephritic Ig from their serum counterparts
[6]. The variations in the location of immune deposits with
individual mAb, observed in the present study, provide new
information relevant to understanding the mechanisms of these
events. The results suggest that the Ag binding region may also
influence the site of immune deposition. Variability in the Ag
binding properties among the individual MRL m anti-DNA Ab
is consistent with this conclusion, and the similarity of Ag
binding properties of the SNF 1 mAb that produce indistinguish-
able patterns of disease also supports this viewpoint (see
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Table 3. In vitro characteristics of MRL-lpr/lpr immune deposit
forming inAb
mAb
# Agemonths Isotype p1
VH gene
family
Antige
ssDNA
n binding propertiesa
dsDNA SmRNP GE
H147 3 IgG2a 8.0 7183 3+ 2+ 1+ 2+
H238 1 1gM 7.5 J558 1+ — 3+ 2+
H221 6 IgG2a 5.1 J558 3+ 3+ 2+ 2+
H161 6 LgG3 7.0 J558 2+ 0 0 0
a As determined in ELISA; scale minimum concentration of mAb
that produced 0D405 >0.500, when positive control mAb reading was
between 1.0—1,2 and negative control mAb <0.050; 3+ <0.1 g/ml;2+ = 0.1—1.0 g/ml; 1+ = 1—10 g/ml; 0 = >10 gIml. Age indicates
age of mouse from which hybridoma was derived.
below). The influence of the antigen binding region among the
MRL mAb is also indicated by differences in VH gene family
use (indicating less that 80% nucleotide sequence homology
between their VH genes) among H147 and H221. These Ig had
markedly different pls and distinguishable antigen binding pro-
files (Table 3 and Results) despite constant region identity
(IgG2a). Collectively these observations raise the possibility
that there may be subsets of pathogenic lupus autoAb, with
distinct cross-reactive Ag binding properties, that are each
responsible for immune deposit formation at distinct locations
within the glomerulus.
One or more of the previously defined mechanisms of im-
mune deposit formation for lupus autoAb may be operative in
these individual circumstances, including cross-reactivity of
autoAb with intrinsic glomerular antigens, in situ formation of
complexes of anti-DNA Ab with autoAg (that have an affinity
for specific sites within the glomerulus), or passive trapping of
circulating immune complexes [11—14, 17, 19, 32—34]. Indeed,
differences in either the site and/or mechanism of immune
deposit formation, determined by the Ag binding region, could
contribute to the observed experimental differences [351. These
possibilities clearly deserve further study. In this regard, fur-
ther investigation of H238 and H 161, including comparison of
their V region sequences and determination of the mechanisms
of immune deposit formation, will be of considerable interest,
because these MRL mAb both produced mesangial and. suben-
dothelial immune deposits.
Although the morphologic pattern of disease varied with the
MRL-derived antibodies, the SNF1 mAb produced mesangial
and capillary wall deposits that were indistinguishable by IF.
These similarities may be explained by nearly identical struc-
ture of three of the four mAb: 550, 564, and 567 have identical
H chain V region sequences (548 has not been sequenced), their
VK sequences differ from each other by only one to three
nucleotides, and their in vitro properties are indistinguishable
[23, 24]. Since cationic amino acid residues within CDR 1 and
CDR 2 distinguish this group of mAb, we suggest that these
residues determine the capacity of this group of pathogenic
autoAb to form immune deposits. Furthermore, since a large
fraction of nephritogenic Ab in this strain share idiotype, charge
and Ag binding properties with this group of autoAb [9, 221, it
is likely that this amino acid sequence motif may strongly
influence disease expression in SNF1 mice. The previous
observation that 548 shares idiotypic properties with 550, 564,
567 and Ig eluted from the kidneys of SNF1 mice is also
consistent with this conclusion. These results also reinforce the
reproducibility of the experimental model and its dependence
on individual properties of the mAb: three independent hybrid-
omas each secreting highly related but distinct 1g. produced
pathologically indistinguishable disease.
The potentiating role of hybridomas in immune deposit
formation deserves additional consideration. We and others
have utilized this method to examine the capacity of individual
autoAb to form immune deposits and transfer disease [14, 31,
361. This approach has some practical and theoretical advan-
tages: (i) it provides high levels of circulating Ig for prolonged
periods, a situation that approximates circulating levels of
autoAb in the serum of individuals with active lupus; (ii) the
intraperitoneal inflammation that accompanies this manipula-
tion may mimic the inflammatory milieu associated with disease
activity; and (iii) the presence of elevated cytokine levels and
other inflammatory mediators could potentially facilitate im-
mune deposit formation either by release of circulating autoan-
tigens or through expression of neoantigens locally within the
kidney. Nevertheless, the extent to which these conditions
exist in individuals with lupus requires confirmation. In the
present studies, the location of the immune deposits were
similar following the i.p. and i.v. maneuvers in most cases,
however, there were two circumstances where the location of
immune deposits were unique to hybridoma administration: the
linear basement membrane deposits observed in some of the
H147 hybridoma mice and the intraluminal deposits associated
with all mice that received the H221 hybridomas. These differ-
ences may have been related to either quantitative differences
in the level of circulating Ab or exposure of neoantigens
induced by the hybridomas. Additional studies are required to
distinguish between these possibilities. It is highly unlikely that
these differences were due to a secondary Ab response (that is,
rheumatoid factor or anti-idiotypic), because additional bands
would have been expected by IEF of Ig derived from the kidney
sections. Furthermore, the hybridoma milieu is known to
suppress production of host Ig [371.
The pathologic and clinical expression of disease varied with
the administered MRL mAb, however, individual mAb always
produced the same abnormalities. It is unlikely that these
differences were due to the capacity of individual Ig to recruit
other Ig (that is, rheumatoid factors, anti-idiotypes) for reasons
discussed previously. The differences in disease expression,
therefore, were most likely related to either quantitative differ-
ences in Ig deposition, the pro-inflammatory properties of
individual mAb and/or the location of immune deposit forma-
tion. Each of these factors is known to influence the morpho-
logic and clinical expression of disease [351. Additional studies
with each mAb will be necessary to distinguish between them.
Nevertheless, these results indicate that individual anti-DNA
Ab can be pathogenic. Furthermore, they raise the possibility
that the Ag binding region of individual autoAg, by determining
the location of immune deposit formation, directly influences
the nature and extent of disease expression.
The influence of Ag binding region on pathogenicity is also
suggested by the recent observations of Reininger and cowork-
ers [311. They compared the pathogenicity of an MRL-lpr/lpr-
derived IgG3k rheumatoid factor with cryoglobulin activity,
termed 6-19, to a hybrid mAb that consisted of the 6-19 heavy
chain and an unrelated lamda light chain. The original autoAb,
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6-19, produced vasculitis and glomerulonephritis, however the
recombinant protein only induced glomerulonephritis. Since the
pathologic profile of the mAb was altered (and presumably the
Fe region was not changed), the results emphasize the contri-
bution of different V region segments to the pathogenicity of an
individual 1g.
The present observations have several important implica-
tions. They suggest that both the site of immune deposit
formation and the resulting pathologic and clinical abnormali-
ties may be dependent on properties unique to subsets of
anti-DNA Ab. In this regard, the lupus nephritis phenotype may
be dependent not only on the quantity and pro-inflammatory
properties of autoAb, but also on the Ag binding properties of
the pathogenic Ig that predominate in a given individual. These
results provide a rationale, therefore, for the investigation of V
region sequences associated with pathogenic autoAb produc-
tion. Moreover, the results raise the possibilities that multiple
Ab-ligand interactions participate in immune deposit formation
in individuals with lupus, and that the predominant autoAb-
autoAg interaction(s), in a given individual, influence both the
morphologic and the clinical expression of nephritis. In the
investigation of pathogenic autoAb (such as, V gene analysis),
therefore, all autoAb are not equal. Consideration should
include both the capacity of individual Ig to transfer disease and
the morphologic and clinical expression of disease that results
from this transfer. Furthermore, consideration of these princi-
ples should also be applied when planning specific therapy
aimed at interrupting the immunologic pathways leading to the
production of pathogenic autoAb in individuals with lupus.
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